---
title: Anti-CRISPR Proteins and Their Application to Control CRISPR Effectors in Mammalian
  Systems
date: '2024-03-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38441767/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240305170555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: CRISPR-Cas effectors are powerful tools for genome and transcriptome
  targeting and editing. Naturally, these protein-RNA complexes are part of the microbial
  innate immune system, which emerged from the evolutionary arms race between microbes
  and phages. This coevolution has also given rise to so-called anti-CRISPR (Acr)
  proteins that counteract the CRISPR-Cas adaptive immunity. Acrs constitutively block
  cognate CRISPR-Cas effectors, e.g., by interfering with guide RNA binding, target
  ...
disable_comments: true
---
CRISPR-Cas effectors are powerful tools for genome and transcriptome targeting and editing. Naturally, these protein-RNA complexes are part of the microbial innate immune system, which emerged from the evolutionary arms race between microbes and phages. This coevolution has also given rise to so-called anti-CRISPR (Acr) proteins that counteract the CRISPR-Cas adaptive immunity. Acrs constitutively block cognate CRISPR-Cas effectors, e.g., by interfering with guide RNA binding, target ...